recombinant fgf4 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
recombinant fgf4
Recombinant Fgf4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 181 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4/Recombinant+Human+FGF-4+Protein/pmc12951759-100-7-9
Average 95 stars, based on 181 article reviews
Recombinant Fgf4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 181 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4/Recombinant+Human+FGF-4+Protein/pmc12951759-100-7-9
Average 95 stars, based on 181 article reviews
recombinant fgf4 - by Bioz Stars,
2026-09
95/100 stars
Images
1) Product Images from "Transcriptional derepression of negative regulators of MAP kinase supports maintenance of diapause ES cells in the pluripotent state"
Article Title: Transcriptional derepression of negative regulators of MAP kinase supports maintenance of diapause ES cells in the pluripotent state
Journal: Genes & Development
doi: 10.1101/gad.353143.125
Figure Legend Snippet: The differentiation block in I-BET-resistant (I-BETR) diapause-like ES cells. ( A ) Alkaline phosphatase (AP) levels in control and I-BETR ES cells. Scale bar, 100 µm. ( B ) Expression levels of the pluripotency ( left panel) or differentiation-inducing ( right panel) genes in control, 2i-treated, or I-BETR ES cells. RNA expression levels were quantified by qPCR. Values represent normalized mean ± SD. n = 3. ( C ) Colony morphology and/or alkaline phosphatase (AP) levels in control and I-BETR ES cells following vehicle or FGF4 triggering. Scale bar, 100 µm. The bar graph represents quantification of relative percentage of pluripotent colonies in different groups. Values represent ± SD. n = 9. (n.s.) No significance, (****) P < 0.0001, one-way ANOVA with Dunnett's multiple comparisons test. ( D ) Expression levels of selected pluripotency ( left ) or differentiation-inducing ( right ) genes in control and I-BETR ES cells treated or not treated with FGF4. Error bars indicate SD. n = 3. (n.s.) No significance, (****) P < 0.0001, one-way ANOVA with Dunnett's multiple comparisons test. ( E ) Withdrawal of I-BET (I-BETW) restores the control ES cell-like pluripotency gene expression pattern in I-BETR ES cells. Values represent gene expression levels normalized to the mean of control samples based on TPM values observed by bulk mRNA RNA-seq analysis . ( F ) Generation of chimeras by I-BETR ES cells. The I-BETR ES cells were incubated in I-BET-free medium for 12–14 h and injected into the C57BL/6J blastocysts. White coat color indicates the chimerism.
Techniques Used: Blocking Assay, Control, Expressing, RNA Expression, Gene Expression, RNA Sequencing, Incubation, Injection
Related Articles
Concentration Assay:Article Title: A human epiblast model reveals dynamic TGFβ-mediated control of epithelial identity during mammalian epiblast development. Article Snippet: Pluripotency, the ability to generate all body cell types, emerges in a disorganized embryonic cell mass.. After implantation, these cells form a columnar epithelium and initiate lumenogenesis.. During gastrulation, some undergo epithelial-to-mesenchymal transition to form the primitive streak (PS). Recombinant:Article Title: Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. Article Snippet: .. Briefly, recombinant human FGF2, Article Title: Shaped organoid compositions and methods of making same Article Snippet: .. Materials: mTeSR1 media (StemCell Technologies); Advanced DMEM-F12 (Invitrogen); RPMI 1640 (Invitrogen); hESC qualified Matrigel (Corning); Defined FBS (Hyclone); L-glutamine (100×) (Invitrogen); penicillin-streptomycin (100×) (Invitrogen); 50×B27 supplement (Invitrogen); HEPES buffer (Invitrogen); Dispase (Invitrogen); Activin A (R&D Systems); In Vitro:Article Title: Reconstructing human early embryogenesis in vitro with pluripotent stem cells Article Snippet: .. In Vitro Culture (IVC) of hEPSC-Derived Structures To prepare plate for in vitro culture, 150 μL of modified IVC1 (mIVC1) media was added to each well of a 96-well ultra-low attachment U-shaped plate (7007, Costar). mIVC1 media consisted of the following: Advanced DMEM/F12 (12634-010; Thermo Fischer Scientific; Waltham, US) supplemented with 20% (vol/vol) heat-inactivated FBS (16141079, Thermo Fisher Scientific), 2 mM GlutaMAXTM, penicillin (25 units/ml)/Streptomycin (25 μg/ml), 1×ITS-X (10 mg/L insulin, 5.5 mg/L transferrin, 0.0067 mg/L sodium selenite, 2 mg/L etholamine; 51500-056; Thermo Fisher Scientific; Waltham, US), 8 nM β-estradiol (E8875; Sigma-Aldrich; St. Louis, US), 200 ng/ml progesterone (P0130; Sigma-Aldrich; St. Louis, US), 25 μM N-acetyl-L-cysteine (A7250; Sigma-Aldrich; St. Louis, US), 17 nm IGF1, 20 ng/ml FGF2 (Gibco), Modification:Article Title: Reconstructing human early embryogenesis in vitro with pluripotent stem cells Article Snippet: .. In Vitro Culture (IVC) of hEPSC-Derived Structures To prepare plate for in vitro culture, 150 μL of modified IVC1 (mIVC1) media was added to each well of a 96-well ultra-low attachment U-shaped plate (7007, Costar). mIVC1 media consisted of the following: Advanced DMEM/F12 (12634-010; Thermo Fischer Scientific; Waltham, US) supplemented with 20% (vol/vol) heat-inactivated FBS (16141079, Thermo Fisher Scientific), 2 mM GlutaMAXTM, penicillin (25 units/ml)/Streptomycin (25 μg/ml), 1×ITS-X (10 mg/L insulin, 5.5 mg/L transferrin, 0.0067 mg/L sodium selenite, 2 mg/L etholamine; 51500-056; Thermo Fisher Scientific; Waltham, US), 8 nM β-estradiol (E8875; Sigma-Aldrich; St. Louis, US), 200 ng/ml progesterone (P0130; Sigma-Aldrich; St. Louis, US), 25 μM N-acetyl-L-cysteine (A7250; Sigma-Aldrich; St. Louis, US), 17 nm IGF1, 20 ng/ml FGF2 (Gibco), |